{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:06:57Z","timestamp":1793210817454,"version":"4.5.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-06168-6","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:27:05Z","timestamp":1784885225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sepsis-related immunosuppression: a comprehensive review of current research breakthroughs"],"prefix":"10.1186","volume":"30","author":[{"given":"Shuai","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"6168_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"6168_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet"},{"key":"6168_CR3","doi-asserted-by":"publisher","first-page":"e2322494","DOI":"10.1001\/jamanetworkopen.2023.22494","volume":"6","author":"Q Bassat","year":"2023","unstructured":"Bassat Q, Blau DM, Ogbuanu IU, Samura S, Kaluma E, Bassey I-A, et al. Causes of Death Among Infants and Children in the Child Health and Mortality Prevention Surveillance (CHAMPS) Network. JAMA Netw Open. 2023;6:e2322494. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.22494.","journal-title":"JAMA Netw Open"},{"key":"6168_CR4","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S2352-4642(24)00140-8","volume":"8","author":"RS Watson","year":"2024","unstructured":"Watson RS, Carrol ED, Carter MJ, Kissoon N, Ranjit S, Schlapbach LJ. The burden and contemporary epidemiology of sepsis in children. Lancet Child Adolesc Health. 2024;8:670\u201381. https:\/\/doi.org\/10.1016\/S2352-4642(24)00140-8.","journal-title":"Lancet Child Adolesc Health"},{"key":"6168_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S2213-2600(18)30063-8","volume":"6","author":"C Fleischmann-Struzek","year":"2018","unstructured":"Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respiratory Med. 2018;6:223\u201330. https:\/\/doi.org\/10.1016\/S2213-2600(18)30063-8.","journal-title":"Lancet Respiratory Med"},{"key":"6168_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jama.2024.0196","volume":"331","author":"LN Sanchez-Pinto","year":"2024","unstructured":"Sanchez-Pinto LN, Bennett TD, DeWitt PE, Russell S, Rebull MN, Martin B, et al. Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024;331:675. https:\/\/doi.org\/10.1001\/jama.2024.0196.","journal-title":"JAMA"},{"key":"6168_CR7","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/SHK.0000000000001915","volume":"57","author":"A Leligdowicz","year":"2022","unstructured":"Leligdowicz A, Kamm J, Kalantar K, Jauregui A, Vessel K, Caldera S, et al. Functional Transcriptomic Studies of Immune Responses and Endotoxin Tolerance in Early Human Sepsis. Shock. 2022;57:180\u201390. https:\/\/doi.org\/10.1097\/SHK.0000000000001915.","journal-title":"Shock"},{"key":"6168_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13613-018-0382-x","volume":"8","author":"S Remy","year":"2018","unstructured":"Remy S, Kolev-Descamps K, Gossez M, Venet F, Demaret J, Javouhey E, et al. Occurrence of marked sepsis-induced immunosuppression in pediatric septic shock: a pilot study. Ann Intensiv Care. 2018;8:36. https:\/\/doi.org\/10.1186\/s13613-018-0382-x.","journal-title":"Ann Intensiv Care"},{"key":"6168_CR9","doi-asserted-by":"publisher","unstructured":"On behalf of the Australian & New Zealand Intensive Care Society (ANZICS) Centre for Outcomes & Resource Evaluation (CORE) and Australian & New Zealand Intensive Care Society (ANZICS) Paediatric Study Group, Schlapbach LJ, MacLaren G, Festa M, Alexander J, Erickson S et al. Prediction of pediatric sepsis mortality within 1\u00a0h of intensive care admission. Intensive Care Med. 2017;43:1085\u201396. https:\/\/doi.org\/10.1007\/s00134-017-4701-8","DOI":"10.1007\/s00134-017-4701-8"},{"key":"6168_CR10","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/PCC.0000000000000385","volume":"16","author":"M Cvetkovic","year":"2015","unstructured":"Cvetkovic M, Lutman D, Ramnarayan P, Pathan N, Inwald DP, Peters MJ. Timing of Death in Children Referred for Intensive Care With Severe Sepsis: Implications for Interventional Studies*. Pediatr Crit Care Med. 2015;16:410\u20137. https:\/\/doi.org\/10.1097\/PCC.0000000000000385.","journal-title":"Pediatr Crit Care Med"},{"key":"6168_CR11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1097\/PCC.0000000000001222","volume":"18","author":"SL Weiss","year":"2017","unstructured":"Weiss SL, Balamuth F, Hensley J, Fitzgerald JC, Bush J, Nadkarni VM, et al. The Epidemiology of Hospital Death Following Pediatric Severe Sepsis: When, Why, and How Children With Sepsis Die*. Pediatr Crit Care Med. 2017;18:823\u201330. https:\/\/doi.org\/10.1097\/PCC.0000000000001222.","journal-title":"Pediatr Crit Care Med"},{"key":"6168_CR12","doi-asserted-by":"publisher","unstructured":"Goldenberg NM, Leligdowicz A, Slutsky AS, Friedrich JO, Lee WL. Is nosocomial infection really the major cause of death in sepsis? Crit Care. 2014;18. https:\/\/doi.org\/10.1186\/s13054-014-0540-y. :540, s13054-014-0540-y.","DOI":"10.1186\/s13054-014-0540-y"},{"key":"6168_CR13","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/s41590-020-0789-z","volume":"21","author":"C Nedeva","year":"2020","unstructured":"Nedeva C, Menassa J, Duan M, Liu C, Doerflinger M, Kueh AJ, et al. TREML4 receptor regulates inflammation and innate immune cell death during polymicrobial sepsis. Nat Immunol. 2020;21:1585\u201396. https:\/\/doi.org\/10.1038\/s41590-020-0789-z.","journal-title":"Nat Immunol"},{"key":"6168_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1172\/JCI82224","volume":"126","author":"MJ Delano","year":"2016","unstructured":"Delano MJ, Ward PA. Sepsis-induced immune dysfunction: can immune therapies reduce mortality? J Clin Invest. 2016;126:23\u201331. https:\/\/doi.org\/10.1172\/JCI82224.","journal-title":"J Clin Invest"},{"key":"6168_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40779-022-00422-y","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang S-Y, Sun J-H, Zhang H-C, Cai Q-L, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Military Med Res. 2022;9:56. https:\/\/doi.org\/10.1186\/s40779-022-00422-y.","journal-title":"Military Med Res"},{"key":"6168_CR16","doi-asserted-by":"publisher","first-page":"h3017","DOI":"10.1136\/bmj.h3017","volume":"350","author":"A Plunkett","year":"2015","unstructured":"Plunkett A, Tong J. Sepsis in children. BMJ. 2015;350:h3017\u20133017. https:\/\/doi.org\/10.1136\/bmj.h3017.","journal-title":"BMJ"},{"key":"6168_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T Van Der Poll","year":"2017","unstructured":"Van Der Poll T, Van De Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017;17:407\u201320. https:\/\/doi.org\/10.1038\/nri.2017.36.","journal-title":"Nat Rev Immunol"},{"key":"6168_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","volume":"40","author":"R Kang","year":"2014","unstructured":"Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, et al. HMGB1 in health and disease. Mol Aspects Med. 2014;40:1\u2013116. https:\/\/doi.org\/10.1016\/j.mam.2014.05.001.","journal-title":"Mol Aspects Med"},{"key":"6168_CR19","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.bjid.2020.09.004","volume":"24","author":"G Sygitowicz","year":"2020","unstructured":"Sygitowicz G, Sitkiewicz D. Molecular mechanisms of organ damage in sepsis: an overview. Brazilian J Infect Dis. 2020;24:552\u201360. https:\/\/doi.org\/10.1016\/j.bjid.2020.09.004.","journal-title":"Brazilian J Infect Dis"},{"key":"6168_CR20","unstructured":"Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH et al. Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure."},{"key":"6168_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013;13:862\u201374. https:\/\/doi.org\/10.1038\/nri3552.","journal-title":"Nat Rev Immunol"},{"key":"6168_CR22","doi-asserted-by":"publisher","first-page":"200111","DOI":"10.1098\/rsob.200111","volume":"10","author":"MM Yaseen","year":"2020","unstructured":"Yaseen MM, Abuharfeil NM, Darmani H, Daoud A. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine. Open Biol. 2020;10:200111. https:\/\/doi.org\/10.1098\/rsob.200111.","journal-title":"Open Biol"},{"key":"6168_CR23","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3389\/fimmu.2020.01299","volume":"11","author":"W-S Ruan","year":"2020","unstructured":"Ruan W-S, Feng M-X, Xu J, Xu Y-G, Song C-Y, Lin L-Y, et al. Early Activation of Myeloid-Derived Suppressor Cells Participate in Sepsis-Induced Immune Suppression via PD-L1\/PD-1 Axis. Front Immunol. 2020;11:1299. https:\/\/doi.org\/10.3389\/fimmu.2020.01299.","journal-title":"Front Immunol"},{"key":"6168_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/biom11071011","volume":"11","author":"C Nedeva","year":"2021","unstructured":"Nedeva C. Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis. Biomolecules. 2021;11:1011. https:\/\/doi.org\/10.3390\/biom11071011.","journal-title":"Biomolecules"},{"key":"6168_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4065362","volume":"2018","author":"JM Patel","year":"2018","unstructured":"Patel JM, Sapey E, Parekh D, Scott A, Dosanjh D, Gao F, et al. Sepsis Induces a Dysregulated Neutrophil Phenotype That Is Associated with Increased Mortality. Mediat Inflamm. 2018;2018:1\u201310. https:\/\/doi.org\/10.1155\/2018\/4065362.","journal-title":"Mediat Inflamm"},{"key":"6168_CR26","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1097\/CCM.0000000000002052","volume":"45","author":"X Li","year":"2017","unstructured":"Li X, Kondo Y, Bao Y, Staudenmaier L, Lee A, Zhang J, et al. Systemic Adenosine Triphosphate Impairs Neutrophil Chemotaxis and Host Defense in Sepsis. Crit Care Med. 2017;45:e97\u2013104. https:\/\/doi.org\/10.1097\/CCM.0000000000002052.","journal-title":"Crit Care Med"},{"key":"6168_CR27","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00134-004-2175-y","volume":"30","author":"AD Chishti","year":"2004","unstructured":"Chishti AD, Shenton BK, Kirby JA, Baudouin SV. Neutrophil chemotaxis and receptor expression in clinical septic shock. Intensive Care Med. 2004;30:605\u201311. https:\/\/doi.org\/10.1007\/s00134-004-2175-y.","journal-title":"Intensive Care Med"},{"key":"6168_CR28","doi-asserted-by":"publisher","unstructured":"S\u00f8rensen, O. E., & Borregaard, N. Neutrophil extracellular traps - the dark side of neutrophils. J Clin Investig. 2016;126(5), 1612\u20131620. https:\/\/doi.org\/10.1172\/JCI84538J Clin Investig. https:\/\/doi.org\/10.1172\/JCI84538","DOI":"10.1172\/JCI84538"},{"key":"6168_CR29","doi-asserted-by":"publisher","unstructured":"Czaikoski PG, Mota JMSC, Nascimento DC, S\u00f4nego F, Castanheira FVES, Melo PH et al. P <>Efron editor 2016 Neutrophil Extracellular Traps Induce Organ Damage during Experimental and Clinical Sepsis. PLoS ONE 11 e0148142 https:\/\/doi.org\/10.1371\/journal.pone.0148142.","DOI":"10.1371\/journal.pone.0148142"},{"key":"6168_CR30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s12026-022-09302-y","volume":"70","author":"M Derigs","year":"2022","unstructured":"Derigs M, Heers H, Lingelbach S, Hofmann R, H\u00e4nze J. Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome. Immunol Res. 2022;70:698\u2013707. https:\/\/doi.org\/10.1007\/s12026-022-09302-y.","journal-title":"Immunol Res"},{"key":"6168_CR31","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/ALN.0000000000000525","volume":"122","author":"J-F Wang","year":"2015","unstructured":"Wang J-F, Li J-B, Zhao Y-J, Yi W-J, Bian J-J, Wan X-J, et al. Up-regulation of Programmed Cell Death 1 Ligand 1 on Neutrophils May Be Involved in Sepsis-induced Immunosuppression: An Animal Study and a Prospective Case-control Study. Anesthesiology. 2015;122:852\u201363. https:\/\/doi.org\/10.1097\/ALN.0000000000000525.","journal-title":"Anesthesiology"},{"key":"6168_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s11658-024-00602-9","volume":"29","author":"L Zheng","year":"2024","unstructured":"Zheng L, Duan Y, He P, Wu M, Wei S, Du X, et al. Dysregulated dendritic cells in sepsis: functional impairment and regulated cell death. Cell Mol Biol Lett. 2024;29:81. https:\/\/doi.org\/10.1186\/s11658-024-00602-9.","journal-title":"Cell Mol Biol Lett"},{"key":"6168_CR33","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1128\/IAI.00238-09","volume":"77","author":"F P\u00e8ne","year":"2009","unstructured":"P\u00e8ne F, Courtine E, Ouaaz F, Zuber B, Sauneuf B, Sirgo G, et al. Toll-Like Receptors 2 and 4 Contribute to Sepsis-Induced Depletion of Spleen Dendritic Cells. Infect Immun. 2009;77:5651\u20138. https:\/\/doi.org\/10.1128\/IAI.00238-09.","journal-title":"Infect Immun"},{"key":"6168_CR34","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.tcb.2013.07.006","volume":"23","author":"K Fernald","year":"2013","unstructured":"Fernald K, Kurokawa M. Evading apoptosis in cancer. Trends Cell Biol. 2013;23:620\u201333. https:\/\/doi.org\/10.1016\/j.tcb.2013.07.006.","journal-title":"Trends Cell Biol"},{"key":"6168_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347\u201364. https:\/\/doi.org\/10.1038\/s41422-019-0164-5.","journal-title":"Cell Res"},{"key":"6168_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/s41418-018-0252-y","volume":"26","author":"D Denton","year":"2019","unstructured":"Denton D, Kumar S. Autophagy-dependent cell death. Cell Death Differ. 2019;26:605\u201316. https:\/\/doi.org\/10.1038\/s41418-018-0252-y.","journal-title":"Cell Death Differ"},{"key":"6168_CR37","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1097\/01.CCM.0000145999.42971.4B","volume":"32","author":"F Venet","year":"2004","unstructured":"Venet F, Pachot A, Debard A-L, Boh\u00e9 J, Bienvenu J, Lepape A, et al. Increased percentage of CD4\u2009+\u2009CD25+ regulatory T cells during septic shock is due to the decrease of CD4\u2009+\u2009CD25\u2013 lymphocytes. Crit Care Med. 2004;32:2329\u201331. https:\/\/doi.org\/10.1097\/01.CCM.0000145999.42971.4B.","journal-title":"Crit Care Med"},{"key":"6168_CR38","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.4049\/jimmunol.177.9.6540","volume":"177","author":"F Venet","year":"2006","unstructured":"Venet F, Pachot A, Debard A-L, Bohe J, Bienvenu J, Lepape A, et al. Human CD4\u2009+\u2009CD25+ Regulatory T Lymphocytes Inhibit Lipopolysaccharide-Induced Monocyte Survival through a Fas\/Fas Ligand-Dependent Mechanism. J Immunol. 2006;177:6540\u20137. https:\/\/doi.org\/10.4049\/jimmunol.177.9.6540.","journal-title":"J Immunol"},{"key":"6168_CR39","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013;13:260\u20138. https:\/\/doi.org\/10.1016\/S1473-3099(13)70001-X.","journal-title":"Lancet Infect Dis"},{"key":"6168_CR40","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/CCM.0000000000002380","volume":"45","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari M, Fear D, Lavender P, Mare T, Beale R, Swanson C, et al. Activation-Associated Accelerated Apoptosis of Memory B Cells in Critically Ill Patients With Sepsis. Crit Care Med. 2017;45:875\u201382. https:\/\/doi.org\/10.1097\/CCM.0000000000002380.","journal-title":"Crit Care Med"},{"key":"6168_CR41","doi-asserted-by":"publisher","first-page":"R105","DOI":"10.1186\/cc12750","volume":"17","author":"J Monserrat","year":"2013","unstructured":"Monserrat J, De Pablo R, Diaz-Mart\u00edn D, Rodr\u00edguez-Zapata M, De La Hera A, Prieto A, et al. Early alterations of B cells in patients with septic shock. Crit Care. 2013;17:R105. https:\/\/doi.org\/10.1186\/cc12750.","journal-title":"Crit Care"},{"key":"6168_CR42","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.4049\/jimmunol.1700929","volume":"200","author":"C-A Gustave","year":"2018","unstructured":"Gustave C-A, Gossez M, Demaret J, Rimmel\u00e9 T, Lepape A, Malcus C, et al. Septic Shock Shapes B Cell Response toward an Exhausted-like\/Immunoregulatory Profile in Patients. J Immunol. 2018;200:2418\u201325. https:\/\/doi.org\/10.4049\/jimmunol.1700929.","journal-title":"J Immunol"},{"key":"6168_CR43","doi-asserted-by":"publisher","first-page":"11740","DOI":"10.3390\/ijms231911740","volume":"23","author":"D Jarczak","year":"2022","unstructured":"Jarczak D, Nierhaus A. Cytokine Storm\u2014Definition, Causes, and Implications. IJMS. 2022;23:11740. https:\/\/doi.org\/10.3390\/ijms231911740.","journal-title":"IJMS"},{"key":"6168_CR44","doi-asserted-by":"publisher","first-page":"8551","DOI":"10.1021\/acsnano.3c00906","volume":"17","author":"Z Li","year":"2023","unstructured":"Li Z, Feng Y, Zhang S, Li T, Li H, Wang D, et al. A Multifunctional Nanoparticle Mitigating Cytokine Storm by Scavenging Multiple Inflammatory Mediators of Sepsis. ACS Nano. 2023;17:8551\u201363. https:\/\/doi.org\/10.1021\/acsnano.3c00906.","journal-title":"ACS Nano"},{"key":"6168_CR45","unstructured":"Hamers L, Kox M, Pickkers P. Sepsis induced immunoparalysis: mechanisms, markers, and treatment options. 2013."},{"key":"6168_CR46","doi-asserted-by":"publisher","first-page":"tkaa040","DOI":"10.1093\/burnst\/tkaa040","volume":"9","author":"S Liu","year":"2021","unstructured":"Liu S, Li Y, She F, Zhao X, Yao Y. Predictive value of immune cell counts and neutrophil-to-lymphocyte ratio for 28-day mortality in patients with sepsis caused by intra-abdominal infection. Burns Trauma. 2021;9:tkaa040. https:\/\/doi.org\/10.1093\/burnst\/tkaa040.","journal-title":"Burns Trauma"},{"key":"6168_CR47","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.4049\/jimmunol.1701618","volume":"200","author":"IJ Jensen","year":"2018","unstructured":"Jensen IJ, Sjaastad FV, Griffith TS, Badovinac VP, Sepsis-Induced T. Cell Immunoparalysis: The Ins and Outs of Impaired T Cell Immunity. J Immunol. 2018;200:1543\u201353. https:\/\/doi.org\/10.4049\/jimmunol.1701618.","journal-title":"J Immunol"},{"key":"6168_CR48","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3389\/fimmu.2019.02179","volume":"10","author":"J Carvelli","year":"2019","unstructured":"Carvelli J, Piperoglou C, Bourenne J, Farnarier C, Banzet N, Demerl\u00e9 C, et al. Imbalance of Circulating Innate Lymphoid Cell Subpopulations in Patients With Septic Shock. Front Immunol. 2019;10:2179. https:\/\/doi.org\/10.3389\/fimmu.2019.02179.","journal-title":"Front Immunol"},{"key":"6168_CR49","doi-asserted-by":"publisher","first-page":"e12813","DOI":"10.1111\/sji.12813","volume":"91","author":"J Xu","year":"2020","unstructured":"Xu J, Li J, Xiao K, Zou S, Yan P, Xie X, et al. Dynamic changes in human HLA-DRA gene expression and Th cell subsets in sepsis: Indications of immunosuppression and associated outcomes. Scand J Immunol. 2020;91:e12813. https:\/\/doi.org\/10.1111\/sji.12813.","journal-title":"Scand J Immunol"},{"key":"6168_CR50","doi-asserted-by":"publisher","first-page":"1356869","DOI":"10.3389\/fimmu.2024.1356869","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Chen L, Peng W, Deng H, Ni H, Tong H, et al. Th17\/Treg balance: the bloom and wane in the pathophysiology of sepsis. Front Immunol. 2024;15:1356869. https:\/\/doi.org\/10.3389\/fimmu.2024.1356869.","journal-title":"Front Immunol"},{"key":"6168_CR51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cyto.2016.09.010","volume":"88","author":"DL Gupta","year":"2016","unstructured":"Gupta DL, Bhoi S, Mohan T, Galwnkar S, Rao DN. Coexistence of Th1\/Th2 and Th17\/Treg imbalances in patients with post traumatic sepsis. Cytokine. 2016;88:214\u201321. https:\/\/doi.org\/10.1016\/j.cyto.2016.09.010.","journal-title":"Cytokine"},{"key":"6168_CR52","doi-asserted-by":"publisher","first-page":"14919","DOI":"10.1038\/ncomms14919","volume":"8","author":"DC Nascimento","year":"2017","unstructured":"Nascimento DC, Melo PH, Pi\u00f1eros AR, Ferreira RG, Col\u00f3n DF, Donate PB, et al. IL-33 contributes to sepsis-induced long-term immunosuppression by expanding the regulatory T cell population. Nat Commun. 2017;8:14919. https:\/\/doi.org\/10.1038\/ncomms14919.","journal-title":"Nat Commun"},{"key":"6168_CR53","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1126\/science.1215173","volume":"335","author":"PJ Rauch","year":"2012","unstructured":"Rauch PJ, Chudnovskiy A, Robbins CS, Weber GF, Etzrodt M, Hilgendorf I, et al. Innate Response Activator B Cells Protect Against Microbial Sepsis. Science. 2012;335:597\u2013601. https:\/\/doi.org\/10.1126\/science.1215173.","journal-title":"Science"},{"key":"6168_CR54","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/joim.12265","volume":"276","author":"JF Bermejo-Mart\u00edn","year":"2014","unstructured":"Bermejo-Mart\u00edn JF, Rodriguez\u2010Fernandez A, Herr\u00e1n\u2010Monge R, Andaluz\u2010Ojeda D, Muriel\u2010Bomb\u00edn A, Merino P, et al. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis. J Intern Med. 2014;276:404\u201312. https:\/\/doi.org\/10.1111\/joim.12265.","journal-title":"J Intern Med"},{"key":"6168_CR55","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrneph.2017.165","volume":"14","author":"F Venet","year":"2018","unstructured":"Venet F, Monneret G. Advances in the understanding and treatment of sepsis-induced immunosuppression. Nat Rev Nephrol. 2018;14:121\u201337. https:\/\/doi.org\/10.1038\/nrneph.2017.165.","journal-title":"Nat Rev Nephrol"},{"key":"6168_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.5847\/wjem.j.1920-8642.2021.03.004","volume":"12","author":"J Yin","year":"2021","unstructured":"Yin J, Chen Y, Huang J, Yan L, Kuang Z, Xue M, et al. Prognosis-related classification and dynamic monitoring of immune status in patients with sepsis: A prospective observational study. World J Emerg Med. 2021;12:185. https:\/\/doi.org\/10.5847\/wjem.j.1920-8642.2021.03.004.","journal-title":"World J Emerg Med"},{"key":"6168_CR57","unstructured":"Chaudhry H, Zhou J, Zhong Y, Ali MM, Mcguire F, Nagarkatti PS et al. Role of Cytokines as a Double-edged Sword in Sepsis. in vivo. 2013."},{"key":"6168_CR58","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ams2.363","volume":"5","author":"E Watanabe","year":"2018","unstructured":"Watanabe E, Thampy LK, Hotchkiss RS. Immunoadjuvant therapy in sepsis: novel strategies for immunosuppressive sepsis coming down the pike. Acute Med Surg. 2018;5:309\u201315. https:\/\/doi.org\/10.1002\/ams2.363.","journal-title":"Acute Med Surg"},{"key":"6168_CR59","doi-asserted-by":"publisher","first-page":"108915","DOI":"10.1016\/j.clim.2021.108915","volume":"235","author":"D Wu","year":"2022","unstructured":"Wu D, Wang L, Hong D, Zheng C, Zeng Y, Ma H, et al. Interleukin 35 contributes to immunosuppression by regulating inflammatory cytokines and T cell populations in the acute phase of sepsis. Clin Immunol. 2022;235:108915. https:\/\/doi.org\/10.1016\/j.clim.2021.108915.","journal-title":"Clin Immunol"},{"key":"6168_CR60","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13054-024-05057-0","volume":"28","author":"C Kassasseya","year":"2024","unstructured":"Kassasseya C, Torsin LI, Musset C, Benhamou M, Chaudry IH, Cavaillon J-M, et al. Divergent effects of tumor necrosis factor (TNF) in sepsis: a meta-analysis of experimental studies. Crit Care. 2024;28:293. https:\/\/doi.org\/10.1186\/s13054-024-05057-0.","journal-title":"Crit Care"},{"key":"6168_CR61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","volume":"37","author":"MW Hall","year":"2011","unstructured":"Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Volk HD, et al. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med. 2011;37:525\u201332. https:\/\/doi.org\/10.1007\/s00134-010-2088-x.","journal-title":"Intensive Care Med"},{"key":"6168_CR62","doi-asserted-by":"publisher","first-page":"e98960","DOI":"10.1172\/jci.insight.98960","volume":"3","author":"B Francois","year":"2018","unstructured":"Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018;3:e98960. https:\/\/doi.org\/10.1172\/jci.insight.98960.","journal-title":"JCI Insight"},{"key":"6168_CR63","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1164\/rccm.2009005","volume":"166","author":"JJ Presneill","year":"2002","unstructured":"Presneill JJ, Harris T, Stewart AG, Cade JF, Wilson JW. A Randomized Phase II Trial of Granulocyte-Macrophage Colony-Stimulating Factor Therapy in Severe Sepsis with Respiratory Dysfunction. Am J Respir Crit Care Med. 2002;166:138\u201343. https:\/\/doi.org\/10.1164\/rccm.2009005.","journal-title":"Am J Respir Crit Care Med"},{"key":"6168_CR64","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/thoraxjnl-2017-211323","volume":"73","author":"EM Pinder","year":"2018","unstructured":"Pinder EM, Rostron AJ, Hellyer TP, Ruchaud-Sparagano M-H, Scott J, Macfarlane JG, et al. Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis. Thorax. 2018;73:918\u201325. https:\/\/doi.org\/10.1136\/thoraxjnl-2017-211323.","journal-title":"Thorax"},{"key":"6168_CR65","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","volume":"180","author":"C Meisel","year":"2009","unstructured":"Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. Granulocyte\u2013Macrophage Colony-stimulating Factor to Reverse Sepsis-associated Immunosuppression: A Double-Blind, Randomized, Placebo-controlled Multicenter Trial. Am J Respir Crit Care Med. 2009;180:640\u20138. https:\/\/doi.org\/10.1164\/rccm.200903-0363OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"6168_CR66","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1189\/jlb.4HI0616-255R","volume":"100","author":"AC Patera","year":"2016","unstructured":"Patera AC, Drewry AM, Chang K, Beiter ER, Osborne D, Hotchkiss RS. Frontline Science: Defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1. J Leukoc Biol. 2016;100:1239\u201354. https:\/\/doi.org\/10.1189\/jlb.4HI0616-255R.","journal-title":"J Leukoc Biol"},{"key":"6168_CR67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s10020-023-00690-x","volume":"29","author":"X Fu","year":"2023","unstructured":"Fu X, Wang Y. Interferon-\u03b3 regulates immunosuppression in septic mice by promoting the Warburg effect through the PI3K\/AKT\/mTOR pathway. Mol Med. 2023;29:95. https:\/\/doi.org\/10.1186\/s10020-023-00690-x.","journal-title":"Mol Med"},{"key":"6168_CR68","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1002\/stem.2695","volume":"35","author":"C Laroye","year":"2017","unstructured":"Laroye C, Gibot S, Reppel L, Bensoussan D. Concise Review: Mesenchymal Stromal\/Stem Cells: A New Treatment for Sepsis and Septic Shock? Stem Cells. 2017;35:2331\u20139. https:\/\/doi.org\/10.1002\/stem.2695.","journal-title":"Stem Cells"},{"key":"6168_CR69","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/ALN.0000000000001882","volume":"127","author":"C Keane","year":"2017","unstructured":"Keane C, Jerkic M, Laffey JG. Stem Cell\u2013based Therapies for Sepsis. Anesthesiology. 2017;127:1017\u201334. https:\/\/doi.org\/10.1097\/ALN.0000000000001882.","journal-title":"Anesthesiology"},{"key":"6168_CR70","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/SHK.0000000000001644","volume":"55","author":"A Khosrojerdi","year":"2021","unstructured":"Khosrojerdi A, Soudi S, Hosseini AZ, Eshghi F, Shafiee A, Hashemi SM. Immunomodulatory and Therapeutic Effects of Mesenchymal Stem Cells on Organ Dysfunction in Sepsis. Shock. 2021;55:423\u201340. https:\/\/doi.org\/10.1097\/SHK.0000000000001644.","journal-title":"Shock"},{"key":"6168_CR71","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1097\/01.CCM.0000295263.12774.97","volume":"35","author":"KG Kreymann","year":"2007","unstructured":"Kreymann KG, De Heer G, Nierhaus A, Kluge S. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock*. Crit Care Med. 2007;35:2677\u201385. https:\/\/doi.org\/10.1097\/01.CCM.0000295263.12774.97.","journal-title":"Crit Care Med"},{"key":"6168_CR72","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/cc10597","volume":"16","author":"M Shankar-Hari","year":"2011","unstructured":"Shankar-Hari M, Spencer J, Sewell WA, Rowan KM, Singer M. Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective. Crit Care. 2011;16:206. https:\/\/doi.org\/10.1186\/cc10597.","journal-title":"Crit Care"},{"key":"6168_CR73","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1007\/s00134-014-3474-6","volume":"40","author":"I Cavazzuti","year":"2014","unstructured":"Cavazzuti I, Serafini G, Busani S, Rinaldi L, Biagioni E, Buoncristiano M, et al. Early therapy with IgM-enriched polyclonal immunoglobulin in patients with septic shock. Intensive Care Med. 2014;40:1888\u201396. https:\/\/doi.org\/10.1007\/s00134-014-3474-6.","journal-title":"Intensive Care Med"},{"key":"6168_CR74","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/MCC.0000000000000639","volume":"25","author":"C Aubron","year":"2019","unstructured":"Aubron C, Berteau F, Sparrow RL. Intravenous immunoglobulin for adjunctive treatment of severe infections in ICUs. Curr Opin Crit Care. 2019;25:417\u201322. https:\/\/doi.org\/10.1097\/MCC.0000000000000639.","journal-title":"Curr Opin Crit Care"},{"key":"6168_CR75","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13054-017-1764-4","volume":"21","author":"Y Iizuka","year":"2017","unstructured":"Iizuka Y, Sanui M, Sasabuchi Y, Lefor AK, Hayakawa M, Saito S, et al. Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock. Crit Care. 2017;21:181. https:\/\/doi.org\/10.1186\/s13054-017-1764-4.","journal-title":"Crit Care"},{"key":"6168_CR76","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s00540-012-1553-9","volume":"27","author":"I Toth","year":"2013","unstructured":"Toth I, Mikor A, Leiner T, Molnar Z, Bogar L, Szakmany T. Effects of IgM-Enriched Immunoglobulin Therapy in Septic-Shock\u2013Induced Multiple Organ Failure: Pilot Study. J Anesth. 2013;27:618\u201322. https:\/\/doi.org\/10.1007\/s00540-012-1553-9.","journal-title":"J Anesth"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06168-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06168-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06168-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T09:27:10Z","timestamp":1784885230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06168-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6168"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06168-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"384"}}